We therefore used EMBER imaging to screen and predict the conformational status of tau deposits in candidate brain samples and, indeed, demonstrated a robust overlap of conformational signatures for NFTs in AD and DS samples (Fig. 2G, H). The gene discussed is MAPT; the disease is Alzheimer disease.